171. ウィルソン病 Wilson disease Clinical trials / Disease details

臨床試験数 : 79 / 薬物数 : 77 - (DrugBank : 17) / 標的遺伝子数 : 6 - 標的パスウェイ数 : 30

17 trials found

diseases per page:

Showing 1 to 10 of 17 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-004135-36-NL (EUCTR)	30/03/2020	16/10/2019	Study to Evaluate the Efficacy and Safety of ALXN1840 in pPtients with Wilson Disease.	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3	United States;Portugal;Serbia;Taiwan;Hong Kong;Greece;Spain;Israel;Russian Federation;Colombia;Italy ...
2	EUCTR2017-004135-36-PT (EUCTR)	13/01/2020	26/03/2019	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3	United States;Portugal;Serbia;Hong Kong;Taiwan;Spain;Israel;Russian Federation;Colombia;France;Denma ...
3	EUCTR2017-004135-36-SE (EUCTR)	29/10/2019	16/04/2019	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Taiwan;Hong Kong;Spain;Russian Federation;Israel;Colombia;France;Austr ...
4	EUCTR2017-004135-36-DK (EUCTR)	16/10/2019	05/08/2019	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: tiomolibdic acid Other descriptive name: BIS-CHOLINE TETRA ...	Alexion Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Taiwan;Hong Kong;Spain;Israel;Russian Federation;Colombia;France;Austr ...
5	EUCTR2019-000905-57-DK (EUCTR)	17/04/2019	14/03/2019	Efficacy of zinc on copper uptake in the body depending on zinc type and dose regimen measured with ...	Efficacy of zinc on human gut copper uptake depending on zinc type and dose regimen quantified with ...	Healthy volunteers (Wilson's disease) MedDRA version: 20.0;Level: LLT;Classification code 10047988;T ...	Trade Name: Wilzin INN or Proposed INN: Zinc acetate Trade Name: Zink Natur-Drogeriet INN or Proposed IN ...	The Department of Hepatology and Gastroenterology, Aarhus University Hospital	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 4	Denmark
6	EUCTR2017-004135-36-FR (EUCTR)	14/09/2018	15/01/2018	A Phase 3 clinical study to Evaluate the Efficacy and Safety of WTX101 in adult patients who suffer ...	A Phase 3, Randomised, Rater-Blinded, Multi-Centre Study to Evaluate the Efficacy and Safety of WTX1 ...	Wilson Disease;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Product Name: WTX101 Product Code: WTX101 INN or Proposed INN: Not applied Other descriptive name: BIS- ...	Wilson Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	102	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;France;Czech Republic;Hungary;Belgi ...
7	EUCTR2017-004135-36-ES (EUCTR)	27/04/2018	22/01/2018	A Phase 3 clinical study to Evaluate the Efficacy and Safety of WTX101 in adult patients who suffer ...	A Phase 3, Randomised, Rater-Blinded, Multi-Centre Study to Evaluate the Efficacy and Safety of WTX1 ...	Wilson Disease;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Product Name: WTX101 Product Code: WTX101 INN or Proposed INN: Not applied Other descriptive name: BIS- ...	Wilson Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	102	Phase 3	France;United States;Hungary;Czech Republic;Poland;Spain;Austria;Israel;Germany;Italy;United Kingdom ...
8	EUCTR2017-004135-36-GB (EUCTR)	23/03/2018	19/12/2017	A Phase 3 clinical study to Evaluate the Efficacy and Safety of WTX101 in adult patients who suffer ...	A Phase 3, Randomised, Rater-Blinded, Multi-Centre Study to Evaluate the Efficacy and Safety of WTX1 ...	Wilson Disease;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Product Name: WTX101 Product Code: WTX101 INN or Proposed INN: Not applied Other descriptive name: BIS- ...	Wilson Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	102	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;France;Czech Republic;Hungary;Belgi ...
9	EUCTR2017-004135-36-DE (EUCTR)	16/03/2018	22/12/2017	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Hong Kong;Taiwan;Greece;Spain;Russian Federation;Israel;Colombia;Franc ...
10	EUCTR2017-004135-36-AT (EUCTR)	27/02/2018	17/01/2018	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Hong Kong;Taiwan;Greece;Spain;Russian Federation;Israel;Colombia;Franc ...

First Previous1 2Next Last